Janet Dunn

21.9k citations
255 papers · 11.4k · 6 hit papers · h-index 47

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Oncology top 0.2%
    • Pancreatic and Hepatic Oncology Research

Papers in

    • Cancer Treatment and Pharmacology 23
    • HER2/EGFR in Cancer Research 15
    • Pancreatic and Hepatic Oncology Research 15
    • Breast Cancer Treatment Studies 52
    • Cancer Genomics and Diagnostics 13

Janet Dunn

244 papers receiving 11.1k citations

Janet Dunn's Hit Papers

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) 2018 · 885 citations
8850+8+16Years since publication50010001.5k

Peers

Janet Dunn
Comparison fields: 5 of 159
  • Internal Medicine 894
  • Oncology 5.5k
  • Cancer Research 1.6k
  • Otorhinolaryngology 457
  • Hematology 930
Replace Sandra L. Wong with:
Sandra L. Wong United States
Elyn Riedel United States
George Fountzilas Greece
Mark F. Munsell United States
Gregory R. Pond Canada
Sylvie Chabaud France
Eleanor McFadden United States
Donna Hollis United States
Andrea Bezjak Canada
Scot C. Remick United States
Janet Dunn relative to Sandra L. Wong United States Sandra L. Wong's profile →
Citations per field
00.5×5.1×
Sandra L. Wong · 1×
Citations per year

Countries citing papers authored by Janet Dunn

Since Specialization
Citations

This map shows the geographic impact of Janet Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Dunn more than expected).

Fields of papers citing papers by Janet Dunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Dunn. The network helps show where Janet Dunn may publish in the future.

Co-authors

The 25 scholars most cited alongside Janet Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janet Dunn Line = papers co-authored together Janet Dunn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 255 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Hit paper breakdown →
20041932
2
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Hit paper breakdown →
2018885
3
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial
Hit paper breakdown →
2001780
4
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
Hit paper breakdown →
2009604
5
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Hit paper breakdown →
2013413
6
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer
Hit paper breakdown →
2016388
7 2005351
8 1998240
9 2015230
10 1994210
11 1994206
12 2016150
13 2001135
14 2006131
15 1991126
16 2017124
17 2005121
18 2002115
19 1996114
20 2003112

About Janet Dunn

Janet Dunn is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Hematology, having authored 255 papers that have together received 11.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (52 papers), Multiple Myeloma Research and Treatments (24 papers), Cancer Treatment and Pharmacology (23 papers), Head and Neck Cancer Studies (20 papers), HER2/EGFR in Cancer Research (15 papers), Pancreatic and Hepatic Oncology Research (15 papers), Advanced Breast Cancer Therapies (14 papers) and Cancer Genomics and Diagnostics (13 papers). The work is most often cited by research in Internal Medicine (894 citations), Oncology (5.5k citations), Cancer Research (1.6k citations), Otorhinolaryngology (457 citations) and Hematology (930 citations). Janet Dunn has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include John P. Neoptolemos, Deborah Stocken, D. Spooner, F Lacaine, Laureano Fernández‐Cruz, Massimo Falconi, Andrea Marshall, Helen Hickey, Christos Dervenis and Markus W. Büchler. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact